Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
105M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
72.6M
-
Shares change
-
+3.87M
-
Total reported value, excl. options
-
$302M
-
Value change
-
+$16.7M
-
Put/Call ratio
-
0.69
-
Number of buys
-
61
-
Number of sells
-
-50
-
Price
-
$4.16
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q4 2024
140 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q4 2024.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.6M shares
of 105M outstanding shares and own 69.15% of the company stock.
Largest 10 shareholders include CADIAN CAPITAL MANAGEMENT, LP (9.34M shares), BlackRock, Inc. (8.02M shares), VANGUARD GROUP INC (5.43M shares), Vitruvian Partners LLP (5.04M shares), MORGAN STANLEY (4.41M shares), MIRABELLA FINANCIAL SERVICES LLP (3.7M shares), RIVER GLOBAL INVESTORS LLP (3.25M shares), Mudita Advisors LLP (3.22M shares), FMR LLC (3.14M shares), and MILLENNIUM MANAGEMENT LLC (2.74M shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.